Thermo Fisher Scientific

Your educational resource for biopharma, pharma, environmental, food and agriculture, industrial, and clinical labs

  • Categories
    • Advancing Materials
    • Advancing Mining
    • AnalyteGuru
    • Analyzing Metals
    • Ask a Scientist
    • Behind the Bench
    • Biotech at Scale
    • Clinical Conversations
    • Examining Food
    • Identifying Threats
    • Illuminating Semiconductors
    • Life in Atomic Resolution
    • Life in the Lab
    • OEMpowered
    • The Connected Lab
  • About Us
  • Contact
Accelerating ScienceAnalyteGuru / MAM / Biopharmaceutical Characterization Complexities: A Dive into Multi-Attribute Method (MAM)

Biopharmaceutical Characterization Complexities: A Dive into Multi-Attribute Method (MAM)

By Lizzie Gallagher, Market Development Manager, Pharma and BioPharma, Thermo Fisher Scientific 03.12.2024

In the fast-changing landscape of biopharmaceuticals, a recent co-authored paper titled “Multi-Attribute Method (MAM): An Emerging Analytical Workflow for Biopharmaceutical Characterization, Batch Release, and cGMP Purity Testing“ discusses the status of MAM providing in-depth knowledge for industry professionals.

In this open-access paper published by the National Institute for Bioprocessing Research and Training and Thermo Fisher Scientific, the need to know about recent advancements in the field of MAM can be found.

Protein characterization
  • Holistic MAM Workflow: The paper details a comprehensive MAM workflow designed for the thorough characterization of biotherapeutics. This methodology, aligned with current Good Manufacturing Practices (cGMP), provides a nuanced understanding of the intricacies involved in the production of biopharmaceuticals.
  • Advanced Trypsin Digestion Method:  Global researchers introduce an improved trypsin digestion method. This innovation aims to minimize digestion-induced modifications on proteins, ensuring the structural integrity of therapeutic proteins.
  • LC-MS Monitoring: The paper explores a liquid chromatography-mass spectrometry (LC-MS) method for simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies. This method transforms the landscape of protein modification identification and quantification.
  • Dalton-Based MAM Innovation: A quadrupole Dalton-based MAM is presented, offering an approach for product characterization, process development, and quality control of therapeutic proteins. This innovation is geared up to redefine the efficiency and precision of monitoring critical quality attributes.
  • Sequence Variant Detection Mastery: The methodologies disclosed in the paper address the persistent challenge of detecting low-level sequence variants in recombinant monoclonal antibodies. This has significant implications for enhancing the reliability of biopharmaceutical development.

Access the Full Paper Here (Open Access): Multi-Attribute Method (MAM): An Emerging Analytical Workflow for Biopharmaceutical Characterization, Batch Release and cGMP Purity Testing at the Peptide and Intact Protein Level

Excedion Pro Banner

Discover. Innovate. Exceed. — Introducing the Thermo Scientific Orbitrap Excedion Pro Mass Spectrometer

Mass spectrometry is entering a new era of precision, perfor...

Read More
Innovation in Biopharma analysis image

Scaling Up Biopharmaceutical Characterization with the Orbitrap Ascend BioPharma Tribrid Mass Spectrometer

Biopharmaceutical pipelines are expanding rapidly, with incr...

Read More
GLP-1 image

Five Key Advantages of the Thermo Scientific LC-MSn Solution for Ultra-Sensitive GLP-1 Quantitation

Bioanalytical analysis using LC-MSn requires precise, accura...

Read More
AAV-SEC Analysis: Top 3 Takeaways From the Latest Article

AAV-SEC Analysis: Top 3 Takeaways From the Latest Article

What is the best column for separating AAV size variants? Th...

Read More

Lizzie Gallagher

Lizzie Gallagher is a market development manager for the pharma and biopharma market at Thermo Fisher Science, having spent a number of years in both industry, and sales and marketing. Lizzie has widespread experience with the challenges and trends of the biopharma and pharma market.
Methylmercury in Edible Fish: How to Detect Critical Levels in Cod and Tuna?
Speed up Drug Development Process With Fit-for-Purpose Metabolite Identification Solutions

Privacy StatementTerms & ConditionsLocationsSitemap

© 2025 Thermo Fisher Scientific. All Rights Reserved.

Talk to us